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LETTER TO THE EDITOR
of lumbar Z score measured by quantitative computedBone remodeling effect of tomography (QCT). This method is more sensitive than
double-energy x-ray absorptiometry (DEXA) to detectcyclosporine protects against changes in the trabecular bone. Indeed, metabolically
active surfaces of trabecular bone are much larger for asteroid-induced osteopenia given volume than those of cortical bone. Furthermore,
QCT measures an actual volumetric density of vertebrae
trabecular bone compared to DEXA, which measuresDelayed reply from authors
an areal projection of bone mineral content of both tra-We thank Goffin et al for pointing out additional con-
becular bone and two layers of cortical bone.founding factors that might account for differences in
Finally, our period of observation was 3 to 24 monthsbone mineral density (BMD) changes as reported in our
while that of Goffin et al was 1 to 12 months post-trans-article published by Kidney International [1]. Since all
plantation. It is well documented that in non-selectedour premenopausal women had normal menstruations
patients lumbar bone loss is predominant during the firstprior to transplantation, a change in their estrogen status
6 months (6.8%), whereas further bone loss between
can be eliminated. With regard to the physical fitness of 6 and 18 months is only 2% [3]. It is remarkable that
all our patients (who received transplants within a year Grotz et al [4], who still found 1% loss during the second
after starting dialysis), their physical status was as good year, found an increase in DEXA BMD when sequential
after transplantation as before. Statins and thiazides, measurements at 12-month intervals were done 3 to 20
which may increase BMD and reduce the risk of fractures years after transplantation while prednisone dose was
[2], was prescribed in none of our patients. Although decreased to a similar level as in our patients (0.12 mg/
the hypercalciuric furosemide was prescribed more fre- kg/day) and cyclosporine dose was 3.4 to 3.8 mg/kg/day,
quently in those whose BMD decreased (60 versus 30%), a little lower than in our patients (about 5 mg/kg/day).
its role in the decrease of BMD in this group is unlikely
Franc¸ois P. Westeel, Hakim Mazouz, Roxane Oprisiu,because the parathyroid hormone (PTH) levels were
and Albert Fourniercomparable in the two groups of patients. Therefore, in Amiens, France
our opinion, we can reasonably eliminate these factors
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provement of the lumbar Z score.
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